FILING ANALYSIS · FRIDAY, OCTOBER 9
Alaunos Therapeutics, Inc. TCRT — 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
negative
Alaunos Therapeutics received a delisting notice from Nasdaq due to non-compliance with the minimum stockholders' equity requirement, and while the company plans to request a hearing and explore strategic alternatives, there is no assurance of regaining compliance or preventing delisting.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →